Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP490366.RAmuQqD1hcAgqtr-weDzCZpExEZBqxpvvxi4GEBfi0fwU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP490366.RAmuQqD1hcAgqtr-weDzCZpExEZBqxpvvxi4GEBfi0fwU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP490366.RAmuQqD1hcAgqtr-weDzCZpExEZBqxpvvxi4GEBfi0fwU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP490366.RAmuQqD1hcAgqtr-weDzCZpExEZBqxpvvxi4GEBfi0fwU130_provenance.
- NP490366.RAmuQqD1hcAgqtr-weDzCZpExEZBqxpvvxi4GEBfi0fwU130_assertion description "[Phosphorylated Y1357 is increased in HER2/neu (v-erb-b2 erythroblastic leukemia viral oncogene homolog 2) mammary tumor epithelia and is required to modulate AIB1/SRC-3 coactivation of estrogen receptor alpha (ERalpha), progesterone receptor B, NF-kappaB, and AP-1-dependent promoters.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP490366.RAmuQqD1hcAgqtr-weDzCZpExEZBqxpvvxi4GEBfi0fwU130_provenance.
- NP490366.RAmuQqD1hcAgqtr-weDzCZpExEZBqxpvvxi4GEBfi0fwU130_assertion evidence source_evidence_literature NP490366.RAmuQqD1hcAgqtr-weDzCZpExEZBqxpvvxi4GEBfi0fwU130_provenance.
- NP490366.RAmuQqD1hcAgqtr-weDzCZpExEZBqxpvvxi4GEBfi0fwU130_assertion SIO_000772 18765637 NP490366.RAmuQqD1hcAgqtr-weDzCZpExEZBqxpvvxi4GEBfi0fwU130_provenance.
- NP490366.RAmuQqD1hcAgqtr-weDzCZpExEZBqxpvvxi4GEBfi0fwU130_assertion wasDerivedFrom befree-20140225 NP490366.RAmuQqD1hcAgqtr-weDzCZpExEZBqxpvvxi4GEBfi0fwU130_provenance.
- NP490366.RAmuQqD1hcAgqtr-weDzCZpExEZBqxpvvxi4GEBfi0fwU130_assertion wasGeneratedBy ECO_0000203 NP490366.RAmuQqD1hcAgqtr-weDzCZpExEZBqxpvvxi4GEBfi0fwU130_provenance.
- befree-20140225 importedOn "2014-02-25" NP490366.RAmuQqD1hcAgqtr-weDzCZpExEZBqxpvvxi4GEBfi0fwU130_provenance.